logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Pfizer Laboratories Div Pfizer Inc drugs

    FiltersReset Filters
    74 results

    • abrilada

      (adalimumab-afzb)
      Pfizer Laboratories Div Pfizer Inc
      Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients 2 years and older.

    • abrilada - adalimumab - afzb

      (Adalimumab-Afzb)
      Pfizer Laboratories Div Pfizer Inc

    • aldactone - spironolactone tablet, film coated

      (Spironolactone)
      Pfizer Laboratories Div Pfizer Inc

    • arthrotec - diclofenac sodium and misoprostol tablet, film coated

      (Diclofenac Sodium And Misoprostol)
      Pfizer Laboratories Div Pfizer Inc

    • azulfidine - sulfasalazine tablet

      (Sulfasalazine)
      Pfizer Laboratories Div Pfizer Inc

    • azulfidine en - tabs - sulfasalazine tablet, delayed release

      (Sulfasalazine)
      Pfizer Laboratories Div Pfizer Inc

    • bicillin c - r 900/300- penicillin g benzathine and penicillin g procaine injection, suspension

      (Penicillin G Benzathine And Penicillin G Procaine)
      Pfizer Laboratories Div Pfizer Inc

    • bicillin cr - penicillin g benzathine and penicillin g procaine injection, suspension

      (Penicillin G Benzathine And Penicillin G Procaine)
      Pfizer Laboratories Div Pfizer Inc

    • bicillin l - a- penicillin g benzathine injection, suspension

      (Penicillin G Benzathine)
      Pfizer Laboratories Div Pfizer Inc

    • bosulif

      (Bosutinib)
      Pfizer Laboratories Div Pfizer Inc
      Usage: BOSULIF is indicated for treating chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in adults and patients aged 1 and older, whether newly diagnosed or resistant/intolerant to prior therapies. It is also used for adult patients with accelerated or blast phases of Ph+ CML who are resistant/intolerant to prior treatments.
      • ...